Y
Ying Xu
Researcher at University of Texas MD Anderson Cancer Center
Publications - 49
Citations - 3696
Ying Xu is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Population & Breast cancer. The author has an hindex of 16, co-authored 42 publications receiving 2615 citations. Previous affiliations of Ying Xu include University of Texas at Austin & Northwestern University.
Papers
More filters
Journal ArticleDOI
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.
Arvind Dasari,Chan Shen,Daniel M. Halperin,Bo Zhao,Shouhao Zhou,Ying Xu,Tina Shih,James C. Yao +7 more
TL;DR: Survival for all NETs has improved over time, especially for distant-stage gastrointestinal NETs and pancreatic NETs in particular, reflecting improvement in therapies.
Journal ArticleDOI
Incidence, Treatment Costs, and Complications of Lymphedema After Breast Cancer Among Women of Working Age: A 2-Year Follow-Up Study
Ya Chen Tina Shih,Ying Xu,Janice N. Cormier,Sharon H. Giordano,Sheila H. Ridner,Thomas A. Buchholz,George H. Perkins,Linda S. Elting +7 more
TL;DR: Although the use of claims data may underestimate the true incidence of lymphedema, women with BCRL had a greater risk of infections and incurred higher medical costs.
Journal ArticleDOI
Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study
Daniel M. Halperin,Chan Shen,Arvind Dasari,Ying Xu,Yiyi Chu,Shouhao Zhou,Ya Chen Tina Shih,James C. Yao +7 more
TL;DR: An improved understanding of the heterogeneity of presenting symptoms among patients with NETs might permit more tailored assessment and management than at present and enable future research into the effect of carcinoid syndrome control on patient survival.
Journal ArticleDOI
Association Between Treatment With Brachytherapy vs Whole-Breast Irradiation and Subsequent Mastectomy, Complications, and Survival Among Older Women With Invasive Breast Cancer
Grace L. Smith,Ying Xu,Thomas A. Buchholz,Sharon H. Giordano,Jing Jiang,Ya Chen Tina Shih,Benjamin Smith +6 more
TL;DR: Treatment with brachytherapy compared with WBI was associated worse with long-term breast preservation and increased complications but no difference in survival in a cohort of older women with breast cancer.
Journal ArticleDOI
Costs of uncontrolled chemotherapy-induced nausea and vomiting among working-age cancer patients receiving highly or moderately emetogenic chemotherapy.
TL;DR: The objective of the project was to estimate the societal costs of uncontrolled CINV among working‐age cancer patients.